{"id":357706,"date":"2025-08-29T10:49:57","date_gmt":"2025-08-29T10:49:57","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-lenz-therapeutics\/"},"modified":"2025-08-29T10:49:57","modified_gmt":"2025-08-29T10:49:57","slug":"how-to-buy-lenz-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/","title":{"rendered":"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-357706","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r - LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r - LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"LENZ Therapeutics (LENZ) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"LENZ Therapeutics (LENZ) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin."},"intro":"Milyonlarca ki\u015fi i\u00e7in g\u00f6rme bak\u0131m\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftiren bir \u015firketin bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. LENZ Therapeutics, FDA onayl\u0131 \u00e7\u0131\u011f\u0131r a\u00e7an g\u00f6z damlas\u0131 tedavisiyle Wall Street'in dikkatini \u00e7ekti. Bu sadece ba\u015fka bir biyoteknoloji hikayesi de\u011fil\u2014d\u00fcnyay\u0131 kelimenin tam anlam\u0131yla g\u00f6rme \u015feklimizi de\u011fi\u015ftirebilecek t\u0131bbi inovasyona ak\u0131ll\u0131 yat\u0131r\u0131m yapmakla ilgili.","intro_source":{"label":"Intro","type":"text","formatted_value":"Milyonlarca ki\u015fi i\u00e7in g\u00f6rme bak\u0131m\u0131n\u0131 devrim niteli\u011finde de\u011fi\u015ftiren bir \u015firketin bir par\u00e7as\u0131na sahip oldu\u011funuzu hayal edin. LENZ Therapeutics, FDA onayl\u0131 \u00e7\u0131\u011f\u0131r a\u00e7an g\u00f6z damlas\u0131 tedavisiyle Wall Street'in dikkatini \u00e7ekti. Bu sadece ba\u015fka bir biyoteknoloji hikayesi de\u011fil\u2014d\u00fcnyay\u0131 kelimenin tam anlam\u0131yla g\u00f6rme \u015feklimizi de\u011fi\u015ftirebilecek t\u0131bbi inovasyona ak\u0131ll\u0131 yat\u0131r\u0131m yapmakla ilgili."},"body_html":"<h2>\ud83d\udcc8 LENZ Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>29 A\u011fustos 2025 itibar\u0131yla, LENZ Therapeutics (LENZ) hisseleri <strong>37,37 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Ancak as\u0131l \u00f6nemli olan \u015fu: takviminize <strong>5 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin\u2014\u015firketin bir sonraki kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 tarih bu. Son tarihlerin ge\u00e7mi\u015fine bak\u0131ld\u0131\u011f\u0131nda bu tarih oyunun seyrini de\u011fi\u015ftirebilir.<\/p> <h3>FDA Haberleri LENZ Hisselerini Nas\u0131l Hareket Ettirir<\/h3> <p>En dramatik fiyat hareketleri d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131ndan gelir. LENZ, 31 Temmuz 2025'te VIZZ i\u00e7in FDA onay\u0131 ald\u0131\u011f\u0131nda, hisse senedi dramatik \u015fekilde y\u00fckseldi. Piyasa verilerine g\u00f6re, onay duyurusunun ard\u0131ndan hisse senedi <strong>%32,2<\/strong> art\u0131\u015f g\u00f6sterdi (<a href=\"https:\/\/www.webull.com\/news\/13321578856088576\">Webull Piyasa Verisi<\/a>).<\/p> <p>Ba\u015fka \u00f6nemli bir s\u0131\u00e7rama, 11 A\u011fustos 2025'te, FDA onay\u0131 ivmesiyle birlikte stratejik ortakl\u0131k duyurular\u0131 nedeniyle \u00f6n piyasa i\u015flemlerinde <strong>%17,33<\/strong> art\u0131\u015f ya\u015fand\u0131 (<a href=\"https:\/\/www.ainvest.com\/news\/lenz-therapeutics-soars-17-33-fda-approval-strategic-partnership-2508\/\">AInvest Raporu<\/a>).<\/p> <h3>Tarihi Kazan\u00e7 Etkisi Deseni<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Fiyat Tepkisi<\/th><th>S\u00fcre<\/th><\/tr> <\/thead> <tbody> <tr><td>30 Tem 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7 A\u00e7\u0131klamas\u0131<\/td><td>Orta d\u00fczey volatilite<\/td><td>2-3 g\u00fcn<\/td><\/tr> <tr><td>31 Tem 2025 FDA Onay\u0131<\/td><td>D\u00fczenleyici d\u00f6n\u00fcm noktas\u0131<\/td><td>%32,2 art\u0131\u015f<\/td><td>S\u00fcrekli<\/td><\/tr> <tr><td>11 A\u011fu 2025<\/td><td>Ortakl\u0131k haberi<\/td><td>%17,33 \u00f6n piyasa<\/td><td>G\u00fcn i\u00e7i<\/td><\/tr> <\/tbody> <\/table> <p>Desen a\u00e7\u0131k: d\u00fczenleyici haberler patlay\u0131c\u0131 hareketler yarat\u0131rken, kazan\u00e7lar daha k\u0131sa vadeli volatiliteye neden olur.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u00d6d\u00fcllerle Dolu Bir Rollercoaster<\/h2> <p>LENZ hisseleri son alt\u0131 ayda inan\u0131lmaz bir y\u00fckseli\u015f ya\u015fad\u0131, \u015eubat 2025'ten bu yana <strong>%77,78<\/strong> kazan\u00e7 sa\u011flad\u0131 (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/LENZ\/chart\/\">MarketBeat Verisi<\/a>). Yolculuk \u015f\u00f6yle geli\u015fti:<\/p> <p><strong>\u015eubat 2025<\/strong>: 21-23 $ aral\u0131\u011f\u0131nda i\u015flem (k\u0131\u015f sonras\u0131 konsolidasyon)<br\/> <strong>Nisan 2025<\/strong>: 28-30 $ aral\u0131\u011f\u0131na s\u0131\u00e7rama (klinik deneme iyimserli\u011fi)<br\/> <strong>Haziran 2025<\/strong>: 35 $+ seviyesine y\u00fckseli\u015f (FDA beklentisi art\u0131yor)<br\/> <strong>A\u011fustos 2025<\/strong>: 41,70 $ zirve (onay sonras\u0131 co\u015fku)<br\/> <strong>G\u00fcncel<\/strong>: 37,37 $ (y\u00fckseklerden sa\u011fl\u0131kl\u0131 geri \u00e7ekilme)<\/p> <p>Hisse senedi, 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesi olan 16,54 $'\u0131n <strong>%56 \u00fczerinde<\/strong> s\u0131\u00e7rayarak yeni zirvelere do\u011fru ivmesini korudu (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/LENZ\/lenz-therapeutics\/stock-price-history\">MacroTrends Analizi<\/a>).<\/p> <h3>Bu \u0130vmenin \u00d6nemi<\/h3> <ul> <li>Ba\u015far\u0131l\u0131 Faz III klinik denemeleri<\/li> <li>Stratejik uluslararas\u0131 ortakl\u0131klar<\/li> <li>209,6 milyon $ g\u00fc\u00e7l\u00fc nakit pozisyonu<\/li> <li>Aseklidin tedavilerinde ilk hareket avantaj\u0131<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2> <p>Kapsaml\u0131 analist kapsam\u0131 ve sekt\u00f6r trendlerine dayanarak, gelecekte \u015funlar olabilir:<\/p> <p><strong>2025 Hedefi<\/strong>: Ortalama 49,75 $ fiyat hedefi (mevcut fiyattan %33 art\u0131\u015f)<br\/> <strong>2026 Projeksiyonu<\/strong>: 65-75 $ aral\u0131\u011f\u0131 (ticari \u00f6l\u00e7eklendirme a\u015famas\u0131)<br\/> <strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 90-110 $ (pazar hakimiyeti kurulmu\u015f)<br\/> <strong>2030 Vizyonu<\/strong>: 150 $+ (k\u00fcresel geni\u015fleme olgunlu\u011fu)<\/p> <p><strong>5 analist<\/strong> aras\u0131nda konsens\u00fcs son derece olumlu, %100'\u00fc Al veya G\u00fc\u00e7l\u00fc Al \u00f6neriyor (<a href=\"https:\/\/stockanalysis.com\/stocks\/lenz\/\">StockAnalysis Verisi<\/a>).<\/p> <h3>Yat\u0131r\u0131m Karar\u0131: G\u00dc\u00c7L\u00dc AL<\/h3> <p>FDA onay\u0131, g\u00fc\u00e7l\u00fc nakit pozisyonu ve devasa pazar f\u0131rsat\u0131n\u0131n birle\u015fimi LENZ'i mevcut seviyelerde cazip bir al\u0131m yap\u0131yor. Risk-getiri oran\u0131 uzun vadeli yat\u0131r\u0131mc\u0131lar lehine.<\/p> <h2>\u26a0\ufe0f Her Yat\u0131r\u0131mc\u0131n\u0131n Dikkate Almas\u0131 Gereken Temel Riskler<\/h2> <h3>Volatilite Tehlikeleri<\/h3> <p>LENZ, <strong>g\u00fcnl\u00fck %4,63 volatilite<\/strong> ve baz\u0131 d\u00f6nemlerde <strong>%40'\u0131n \u00fczerinde standart sapmalar<\/strong> g\u00f6steriyor (<a href=\"https:\/\/stockinvest.us\/stock\/LENZ\">StockInvest Analizi<\/a>). Bu, yat\u0131r\u0131m\u0131n\u0131z\u0131n g\u00fcn i\u00e7inde b\u00fcy\u00fck dalgalanmalar ya\u015fayabilece\u011fi anlam\u0131na gelir.<\/p> <h3>Mali Zorluklar<\/h3> <p>\u015eirket, <strong>ileriye d\u00f6n\u00fck F\/K oran\u0131 -11,77<\/strong> ve <strong>-40,5 milyon $ negatif serbest nakit ak\u0131\u015f\u0131<\/strong> bildiriyor (<a href=\"https:\/\/www.directorstalkinterviews.com\/lenz-therapeutics-inc-lenz-investor-outlook-on-a-biotech-with-48-upside-potential\/4121203452\">DirectorTalk Verisi<\/a>). Geli\u015fim a\u015famas\u0131ndaki biyoteknoloji \u015firketleri i\u00e7in tipik olsa da dikkatli izlenmeli.<\/p> <h3>D\u00fczenleyici Engeller<\/h3> <p>FDA onay\u0131na ra\u011fmen, geni\u015fleme veya ek endikasyonlar i\u00e7in gelecekteki d\u00fczenleyici gereksinimler beklenmedik gecikmeler veya maliyetler yaratabilir.<\/p> <h2>\ud83d\udfe2 2025 Yat\u0131r\u0131m\u0131 \u0130\u00e7in Olumlu Sinyaller<\/h2> <h3>Oyun De\u011fi\u015ftiren FDA Onay\u0131<\/h3> <p>A\u011fustos 2025'te onaylanan VIZZ\u2014ilk aseklidin bazl\u0131 presbiyopi tedavisi\u2014s\u0131n\u0131rl\u0131 rekabetle <strong>milyar dolarl\u0131k pazar f\u0131rsat\u0131<\/strong> yarat\u0131yor.<\/p> <h3>Stratejik Ortakl\u0131klar<\/h3> <p>Uluslararas\u0131 lisans anla\u015fmalar\u0131, <strong>195+ milyon $ \u00f6n \u00f6deme<\/strong> ve gelecekteki sat\u0131\u015flardan \u00e7ift haneli telif haklar\u0131 sa\u011flad\u0131 (<a href=\"https:\/\/ir.lenz-tx.com\/news-events\/press-releases\/detail\/38\/lenz-therapeutics-reports-second-quarter-2025-financial-results-and-recent-corporate-highlights\">\u015eirket Raporu<\/a>).<\/p> <h3>Nakit G\u00fcvencesi<\/h3> <p><strong>209,6 milyon $ nakit rezervi<\/strong> ile LENZ, ticari lansman ve devam eden geli\u015ftirme i\u00e7in yeterli finansmana sahip, hemen sermaye art\u0131r\u0131m\u0131 endi\u015fesi yok.<\/p> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong> - Zamanlama riskini azaltmak i\u00e7in toplu de\u011fil par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li> <li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong> - Potansiyel giri\u015f f\u0131rsatlar\u0131 i\u00e7in 5 Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin<\/li> <li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong> - Biyoteknoloji yat\u0131r\u0131mlar\u0131 klinik ve ticari a\u015famalarda sab\u0131r gerektirir<\/li> <\/ol> <p><em>Esprili deneyimli t\u00fcccar bilgeli\u011fi: \"LENZ ticareti yapmak, onlar\u0131n g\u00f6z damlalar\u0131n\u0131 kullanmak gibidir\u2014net g\u00f6r\u00fc\u015f i\u00e7in m\u00fckemmel zamanlama gerekir, ama yanl\u0131\u015f anda k\u0131rp\u0131nca her \u015fey bulan\u0131kla\u015f\u0131r!\"<\/em><\/p> <h2>\u2705 LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Modern platformlar herhangi bir kimlik belgesi ile 1 dakikal\u0131k KYC sunar<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131za para yat\u0131r\u0131n<\/td><td>Volatiliteye haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"LENZ\" sembol\u00fcn\u00fc aray\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon oranlar\u0131n\u0131 kontrol edin\u2014i\u015flem ba\u015f\u0131na %0,5'in alt\u0131nda hedefleyin<\/td><\/tr> <tr><td>7<\/td><td>Pozisyonunuzu izleyin<\/td><td>Kazan\u00e7 tarihleri ve fiyat hedefleri i\u00e7in uyar\u0131lar kurun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 LENZ Yat\u0131r\u0131m\u0131 \u0130\u00e7in Pocket Option Neden Mant\u0131kl\u0131?<\/h2> <p>LENZ Therapeutics gibi yenilik\u00e7i \u015firketlerde pozisyon olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option belirgin avantajlar sunar:<\/p> <p><strong>Sadece 5 $ minimum depozito<\/strong> ile biyoteknoloji sekt\u00f6r dinamiklerini \u00f6\u011frenirken stratejileri d\u00fc\u015f\u00fck riskle test edebilirsiniz. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> sayesinde karar verdikten hemen sonra i\u015flem yapmaya ba\u015flayabilirsiniz. <strong>100+ \u00e7ekim y\u00f6ntemi<\/strong> aras\u0131nda \u00e7e\u015fitli kripto paralar ve e-c\u00fczdanlar bulunur, b\u00f6ylece yat\u0131r\u0131m getirilerinizde esneklik sa\u011flars\u0131n\u0131z.<\/p> <p>D\u00fc\u015f\u00fck giri\u015f engelleri ve g\u00fc\u00e7l\u00fc ticaret ara\u00e7lar\u0131n\u0131n birle\u015fimi, Pocket Option'u LENZ gibi y\u00fcksek potansiyelli hisselere maruz kalmak isteyen ancak ba\u015flang\u0131\u00e7ta b\u00fcy\u00fck sermaye taahh\u00fct etmek istemeyen yat\u0131r\u0131mc\u0131lar i\u00e7in ideal k\u0131lar.<\/p> <h2>\ud83c\udf0d 2025'te LENZ Therapeutics: Vizyoner Liderlik<\/h2> <p>LENZ Therapeutics, klinik a\u015fama \u015firketinden presbiyopi tedavisinde ticari liderli\u011fe d\u00f6n\u00fc\u015ft\u00fc. \u015eirketin \"t\u00fcm g\u00f6zler i\u00e7in, t\u00fcm g\u00fcn boyunca g\u00f6r\u00fc\u015f\u00fc art\u0131ran ideal bir farmas\u00f6tik presbiyopi \u00e7\u00f6z\u00fcm\u00fc geli\u015ftirme\" odaklanmas\u0131, onlar\u0131 oftalmoloji pazar\u0131nda benzersiz konuma getirdi (<a href=\"https:\/\/ir.lenz-tx.com\">\u015eirket Web Sitesi<\/a>).<\/p> <p>FDA onayl\u0131 VIZZ tedavisi Ekim 2025'te \u00f6rnekler \u00fcretmeye ba\u015flad\u0131 ve tam ticari da\u011f\u0131t\u0131m 2025 4. \u00e7eyrek ortas\u0131 hedefleniyor; LENZ, bilimsel inovasyon ve ticari uygulaman\u0131n nadir birle\u015fimini temsil ediyor.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda LENZ Therapeutics'in 88 uzmanl\u0131k sat\u0131\u015f ekibi, oftalmoloji tarihindeki en e\u011fitimli farmas\u00f6tik sat\u0131\u015f g\u00fc\u00e7lerinden biri oldu\u2014her \u00fcye presbiyopi bilimi ve aseklidin benzersiz etki mekanizmas\u0131 hakk\u0131nda kapsaml\u0131 e\u011fitim ald\u0131, b\u00f6ylece g\u00f6z bak\u0131m profesyonellerini bu \u00e7\u0131\u011f\u0131r a\u00e7an tedavi yakla\u015f\u0131m\u0131 hakk\u0131nda e\u011fitebiliyorlar.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 LENZ Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>29 A\u011fustos 2025 itibar\u0131yla, LENZ Therapeutics (LENZ) hisseleri <strong>37,37 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Ancak as\u0131l \u00f6nemli olan \u015fu: takviminize <strong>5 Kas\u0131m 2025<\/strong> tarihini i\u015faretleyin\u2014\u015firketin bir sonraki kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 tarih bu. Son tarihlerin ge\u00e7mi\u015fine bak\u0131ld\u0131\u011f\u0131nda bu tarih oyunun seyrini de\u011fi\u015ftirebilir.<\/p>\n<h3>FDA Haberleri LENZ Hisselerini Nas\u0131l Hareket Ettirir<\/h3>\n<p>En dramatik fiyat hareketleri d\u00fczenleyici d\u00f6n\u00fcm noktalar\u0131ndan gelir. LENZ, 31 Temmuz 2025&#8217;te VIZZ i\u00e7in FDA onay\u0131 ald\u0131\u011f\u0131nda, hisse senedi dramatik \u015fekilde y\u00fckseldi. Piyasa verilerine g\u00f6re, onay duyurusunun ard\u0131ndan hisse senedi <strong>%32,2<\/strong> art\u0131\u015f g\u00f6sterdi (<a href=\"https:\/\/www.webull.com\/news\/13321578856088576\">Webull Piyasa Verisi<\/a>).<\/p>\n<p>Ba\u015fka \u00f6nemli bir s\u0131\u00e7rama, 11 A\u011fustos 2025&#8217;te, FDA onay\u0131 ivmesiyle birlikte stratejik ortakl\u0131k duyurular\u0131 nedeniyle \u00f6n piyasa i\u015flemlerinde <strong>%17,33<\/strong> art\u0131\u015f ya\u015fand\u0131 (<a href=\"https:\/\/www.ainvest.com\/news\/lenz-therapeutics-soars-17-33-fda-approval-strategic-partnership-2508\/\">AInvest Raporu<\/a>).<\/p>\n<h3>Tarihi Kazan\u00e7 Etkisi Deseni<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Fiyat Tepkisi<\/th>\n<th>S\u00fcre<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>30 Tem 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7 A\u00e7\u0131klamas\u0131<\/td>\n<td>Orta d\u00fczey volatilite<\/td>\n<td>2-3 g\u00fcn<\/td>\n<\/tr>\n<tr>\n<td>31 Tem 2025 FDA Onay\u0131<\/td>\n<td>D\u00fczenleyici d\u00f6n\u00fcm noktas\u0131<\/td>\n<td>%32,2 art\u0131\u015f<\/td>\n<td>S\u00fcrekli<\/td>\n<\/tr>\n<tr>\n<td>11 A\u011fu 2025<\/td>\n<td>Ortakl\u0131k haberi<\/td>\n<td>%17,33 \u00f6n piyasa<\/td>\n<td>G\u00fcn i\u00e7i<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Desen a\u00e7\u0131k: d\u00fczenleyici haberler patlay\u0131c\u0131 hareketler yarat\u0131rken, kazan\u00e7lar daha k\u0131sa vadeli volatiliteye neden olur.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u00d6d\u00fcllerle Dolu Bir Rollercoaster<\/h2>\n<p>LENZ hisseleri son alt\u0131 ayda inan\u0131lmaz bir y\u00fckseli\u015f ya\u015fad\u0131, \u015eubat 2025&#8217;ten bu yana <strong>%77,78<\/strong> kazan\u00e7 sa\u011flad\u0131 (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/LENZ\/chart\/\">MarketBeat Verisi<\/a>). Yolculuk \u015f\u00f6yle geli\u015fti:<\/p>\n<p><strong>\u015eubat 2025<\/strong>: 21-23 $ aral\u0131\u011f\u0131nda i\u015flem (k\u0131\u015f sonras\u0131 konsolidasyon)<br \/> <strong>Nisan 2025<\/strong>: 28-30 $ aral\u0131\u011f\u0131na s\u0131\u00e7rama (klinik deneme iyimserli\u011fi)<br \/> <strong>Haziran 2025<\/strong>: 35 $+ seviyesine y\u00fckseli\u015f (FDA beklentisi art\u0131yor)<br \/> <strong>A\u011fustos 2025<\/strong>: 41,70 $ zirve (onay sonras\u0131 co\u015fku)<br \/> <strong>G\u00fcncel<\/strong>: 37,37 $ (y\u00fckseklerden sa\u011fl\u0131kl\u0131 geri \u00e7ekilme)<\/p>\n<p>Hisse senedi, 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesi olan 16,54 $&#8217;\u0131n <strong>%56 \u00fczerinde<\/strong> s\u0131\u00e7rayarak yeni zirvelere do\u011fru ivmesini korudu (<a href=\"https:\/\/www.macrotrends.net\/stocks\/charts\/LENZ\/lenz-therapeutics\/stock-price-history\">MacroTrends Analizi<\/a>).<\/p>\n<h3>Bu \u0130vmenin \u00d6nemi<\/h3>\n<ul>\n<li>Ba\u015far\u0131l\u0131 Faz III klinik denemeleri<\/li>\n<li>Stratejik uluslararas\u0131 ortakl\u0131klar<\/li>\n<li>209,6 milyon $ g\u00fc\u00e7l\u00fc nakit pozisyonu<\/li>\n<li>Aseklidin tedavilerinde ilk hareket avantaj\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2>\n<p>Kapsaml\u0131 analist kapsam\u0131 ve sekt\u00f6r trendlerine dayanarak, gelecekte \u015funlar olabilir:<\/p>\n<p><strong>2025 Hedefi<\/strong>: Ortalama 49,75 $ fiyat hedefi (mevcut fiyattan %33 art\u0131\u015f)<br \/> <strong>2026 Projeksiyonu<\/strong>: 65-75 $ aral\u0131\u011f\u0131 (ticari \u00f6l\u00e7eklendirme a\u015famas\u0131)<br \/> <strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 90-110 $ (pazar hakimiyeti kurulmu\u015f)<br \/> <strong>2030 Vizyonu<\/strong>: 150 $+ (k\u00fcresel geni\u015fleme olgunlu\u011fu)<\/p>\n<p><strong>5 analist<\/strong> aras\u0131nda konsens\u00fcs son derece olumlu, %100&#8217;\u00fc Al veya G\u00fc\u00e7l\u00fc Al \u00f6neriyor (<a href=\"https:\/\/stockanalysis.com\/stocks\/lenz\/\">StockAnalysis Verisi<\/a>).<\/p>\n<h3>Yat\u0131r\u0131m Karar\u0131: G\u00dc\u00c7L\u00dc AL<\/h3>\n<p>FDA onay\u0131, g\u00fc\u00e7l\u00fc nakit pozisyonu ve devasa pazar f\u0131rsat\u0131n\u0131n birle\u015fimi LENZ&#8217;i mevcut seviyelerde cazip bir al\u0131m yap\u0131yor. Risk-getiri oran\u0131 uzun vadeli yat\u0131r\u0131mc\u0131lar lehine.<\/p>\n<h2>\u26a0\ufe0f Her Yat\u0131r\u0131mc\u0131n\u0131n Dikkate Almas\u0131 Gereken Temel Riskler<\/h2>\n<h3>Volatilite Tehlikeleri<\/h3>\n<p>LENZ, <strong>g\u00fcnl\u00fck %4,63 volatilite<\/strong> ve baz\u0131 d\u00f6nemlerde <strong>%40&#8217;\u0131n \u00fczerinde standart sapmalar<\/strong> g\u00f6steriyor (<a href=\"https:\/\/stockinvest.us\/stock\/LENZ\">StockInvest Analizi<\/a>). Bu, yat\u0131r\u0131m\u0131n\u0131z\u0131n g\u00fcn i\u00e7inde b\u00fcy\u00fck dalgalanmalar ya\u015fayabilece\u011fi anlam\u0131na gelir.<\/p>\n<h3>Mali Zorluklar<\/h3>\n<p>\u015eirket, <strong>ileriye d\u00f6n\u00fck F\/K oran\u0131 -11,77<\/strong> ve <strong>-40,5 milyon $ negatif serbest nakit ak\u0131\u015f\u0131<\/strong> bildiriyor (<a href=\"https:\/\/www.directorstalkinterviews.com\/lenz-therapeutics-inc-lenz-investor-outlook-on-a-biotech-with-48-upside-potential\/4121203452\">DirectorTalk Verisi<\/a>). Geli\u015fim a\u015famas\u0131ndaki biyoteknoloji \u015firketleri i\u00e7in tipik olsa da dikkatli izlenmeli.<\/p>\n<h3>D\u00fczenleyici Engeller<\/h3>\n<p>FDA onay\u0131na ra\u011fmen, geni\u015fleme veya ek endikasyonlar i\u00e7in gelecekteki d\u00fczenleyici gereksinimler beklenmedik gecikmeler veya maliyetler yaratabilir.<\/p>\n<h2>\ud83d\udfe2 2025 Yat\u0131r\u0131m\u0131 \u0130\u00e7in Olumlu Sinyaller<\/h2>\n<h3>Oyun De\u011fi\u015ftiren FDA Onay\u0131<\/h3>\n<p>A\u011fustos 2025&#8217;te onaylanan VIZZ\u2014ilk aseklidin bazl\u0131 presbiyopi tedavisi\u2014s\u0131n\u0131rl\u0131 rekabetle <strong>milyar dolarl\u0131k pazar f\u0131rsat\u0131<\/strong> yarat\u0131yor.<\/p>\n<h3>Stratejik Ortakl\u0131klar<\/h3>\n<p>Uluslararas\u0131 lisans anla\u015fmalar\u0131, <strong>195+ milyon $ \u00f6n \u00f6deme<\/strong> ve gelecekteki sat\u0131\u015flardan \u00e7ift haneli telif haklar\u0131 sa\u011flad\u0131 (<a href=\"https:\/\/ir.lenz-tx.com\/news-events\/press-releases\/detail\/38\/lenz-therapeutics-reports-second-quarter-2025-financial-results-and-recent-corporate-highlights\">\u015eirket Raporu<\/a>).<\/p>\n<h3>Nakit G\u00fcvencesi<\/h3>\n<p><strong>209,6 milyon $ nakit rezervi<\/strong> ile LENZ, ticari lansman ve devam eden geli\u015ftirme i\u00e7in yeterli finansmana sahip, hemen sermaye art\u0131r\u0131m\u0131 endi\u015fesi yok.<\/p>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 kullan\u0131n<\/strong> &#8211; Zamanlama riskini azaltmak i\u00e7in toplu de\u011fil par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li>\n<li><strong>Fiyat uyar\u0131lar\u0131 kurun<\/strong> &#8211; Potansiyel giri\u015f f\u0131rsatlar\u0131 i\u00e7in 5 Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin<\/li>\n<li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong> &#8211; Biyoteknoloji yat\u0131r\u0131mlar\u0131 klinik ve ticari a\u015famalarda sab\u0131r gerektirir<\/li>\n<\/ol>\n<p><em>Esprili deneyimli t\u00fcccar bilgeli\u011fi: &#8220;LENZ ticareti yapmak, onlar\u0131n g\u00f6z damlalar\u0131n\u0131 kullanmak gibidir\u2014net g\u00f6r\u00fc\u015f i\u00e7in m\u00fckemmel zamanlama gerekir, ama yanl\u0131\u015f anda k\u0131rp\u0131nca her \u015fey bulan\u0131kla\u015f\u0131r!&#8221;<\/em><\/p>\n<h2>\u2705 LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Modern platformlar herhangi bir kimlik belgesi ile 1 dakikal\u0131k KYC sunar<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131za para yat\u0131r\u0131n<\/td>\n<td>Volatiliteye haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;LENZ&#8221; sembol\u00fcn\u00fc aray\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Volatil hisselerde giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon oranlar\u0131n\u0131 kontrol edin\u2014i\u015flem ba\u015f\u0131na %0,5&#8217;in alt\u0131nda hedefleyin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonunuzu izleyin<\/td>\n<td>Kazan\u00e7 tarihleri ve fiyat hedefleri i\u00e7in uyar\u0131lar kurun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 LENZ Yat\u0131r\u0131m\u0131 \u0130\u00e7in Pocket Option Neden Mant\u0131kl\u0131?<\/h2>\n<p>LENZ Therapeutics gibi yenilik\u00e7i \u015firketlerde pozisyon olu\u015fturmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option belirgin avantajlar sunar:<\/p>\n<p><strong>Sadece 5 $ minimum depozito<\/strong> ile biyoteknoloji sekt\u00f6r dinamiklerini \u00f6\u011frenirken stratejileri d\u00fc\u015f\u00fck riskle test edebilirsiniz. Platformun <strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong> sayesinde karar verdikten hemen sonra i\u015flem yapmaya ba\u015flayabilirsiniz. <strong>100+ \u00e7ekim y\u00f6ntemi<\/strong> aras\u0131nda \u00e7e\u015fitli kripto paralar ve e-c\u00fczdanlar bulunur, b\u00f6ylece yat\u0131r\u0131m getirilerinizde esneklik sa\u011flars\u0131n\u0131z.<\/p>\n<p>D\u00fc\u015f\u00fck giri\u015f engelleri ve g\u00fc\u00e7l\u00fc ticaret ara\u00e7lar\u0131n\u0131n birle\u015fimi, Pocket Option&#8217;u LENZ gibi y\u00fcksek potansiyelli hisselere maruz kalmak isteyen ancak ba\u015flang\u0131\u00e7ta b\u00fcy\u00fck sermaye taahh\u00fct etmek istemeyen yat\u0131r\u0131mc\u0131lar i\u00e7in ideal k\u0131lar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te LENZ Therapeutics: Vizyoner Liderlik<\/h2>\n<p>LENZ Therapeutics, klinik a\u015fama \u015firketinden presbiyopi tedavisinde ticari liderli\u011fe d\u00f6n\u00fc\u015ft\u00fc. \u015eirketin &#8220;t\u00fcm g\u00f6zler i\u00e7in, t\u00fcm g\u00fcn boyunca g\u00f6r\u00fc\u015f\u00fc art\u0131ran ideal bir farmas\u00f6tik presbiyopi \u00e7\u00f6z\u00fcm\u00fc geli\u015ftirme&#8221; odaklanmas\u0131, onlar\u0131 oftalmoloji pazar\u0131nda benzersiz konuma getirdi (<a href=\"https:\/\/ir.lenz-tx.com\">\u015eirket Web Sitesi<\/a>).<\/p>\n<p>FDA onayl\u0131 VIZZ tedavisi Ekim 2025&#8217;te \u00f6rnekler \u00fcretmeye ba\u015flad\u0131 ve tam ticari da\u011f\u0131t\u0131m 2025 4. \u00e7eyrek ortas\u0131 hedefleniyor; LENZ, bilimsel inovasyon ve ticari uygulaman\u0131n nadir birle\u015fimini temsil ediyor.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda LENZ Therapeutics&#8217;in 88 uzmanl\u0131k sat\u0131\u015f ekibi, oftalmoloji tarihindeki en e\u011fitimli farmas\u00f6tik sat\u0131\u015f g\u00fc\u00e7lerinden biri oldu\u2014her \u00fcye presbiyopi bilimi ve aseklidin benzersiz etki mekanizmas\u0131 hakk\u0131nda kapsaml\u0131 e\u011fitim ald\u0131, b\u00f6ylece g\u00f6z bak\u0131m profesyonellerini bu \u00e7\u0131\u011f\u0131r a\u00e7an tedavi yakla\u015f\u0131m\u0131 hakk\u0131nda e\u011fitebiliyorlar.<\/p>\n"},"faq":[{"question":"LENZ Therapeutics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131za para yat\u0131r\u0131n, \"LENZ\" sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak sipari\u015f verin ve pozisyonunuzu kazan\u00e7 tarihleri ve fiyat hedefleri i\u00e7in izleyin."},{"question":"LENZ hisselerinin riskleri nelerdir?","answer":"LENZ hisseleri y\u00fcksek volatiliteye sahiptir (%4,63 g\u00fcnl\u00fck volatilite) ve negatif serbest nakit ak\u0131\u015f\u0131 gibi finansal zorluklar i\u00e7erebilir. Ayr\u0131ca d\u00fczenleyici engeller ve piyasa dalgalanmalar\u0131 riski vard\u0131r."},{"question":"LENZ Therapeutics'in FDA onay\u0131n\u0131n \u00f6nemi nedir?","answer":"FDA onay\u0131, VIZZ adl\u0131 ilk aseklidin bazl\u0131 presbiyopi tedavisinin piyasaya s\u00fcr\u00fclmesini sa\u011flad\u0131 ve bu da milyar dolarl\u0131k bir pazar f\u0131rsat\u0131 yaratt\u0131."},{"question":"LENZ hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 i\u00e7in hedef fiyat 49,75 $ (mevcut fiyattan %33 art\u0131\u015f), 2026 i\u00e7in 65-75 $, 2028 i\u00e7in 90-110 $ ve 2030 i\u00e7in 150 $+ olarak \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayanlar LENZ hisseleri i\u00e7in ne yapmal\u0131?","answer":"Portf\u00f6y\u00fcn %5'inden fazlas\u0131n\u0131 ay\u0131rmamak, dolar maliyeti ortalamas\u0131 kullanmak, fiyat uyar\u0131lar\u0131 kurmak ve uzun vadeli d\u00fc\u015f\u00fcnmek \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"LENZ Therapeutics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131za para yat\u0131r\u0131n, \"LENZ\" sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak sipari\u015f verin ve pozisyonunuzu kazan\u00e7 tarihleri ve fiyat hedefleri i\u00e7in izleyin."},{"question":"LENZ hisselerinin riskleri nelerdir?","answer":"LENZ hisseleri y\u00fcksek volatiliteye sahiptir (%4,63 g\u00fcnl\u00fck volatilite) ve negatif serbest nakit ak\u0131\u015f\u0131 gibi finansal zorluklar i\u00e7erebilir. Ayr\u0131ca d\u00fczenleyici engeller ve piyasa dalgalanmalar\u0131 riski vard\u0131r."},{"question":"LENZ Therapeutics'in FDA onay\u0131n\u0131n \u00f6nemi nedir?","answer":"FDA onay\u0131, VIZZ adl\u0131 ilk aseklidin bazl\u0131 presbiyopi tedavisinin piyasaya s\u00fcr\u00fclmesini sa\u011flad\u0131 ve bu da milyar dolarl\u0131k bir pazar f\u0131rsat\u0131 yaratt\u0131."},{"question":"LENZ hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 i\u00e7in hedef fiyat 49,75 $ (mevcut fiyattan %33 art\u0131\u015f), 2026 i\u00e7in 65-75 $, 2028 i\u00e7in 90-110 $ ve 2030 i\u00e7in 150 $+ olarak \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Yeni ba\u015flayanlar LENZ hisseleri i\u00e7in ne yapmal\u0131?","answer":"Portf\u00f6y\u00fcn %5'inden fazlas\u0131n\u0131 ay\u0131rmamak, dolar maliyeti ortalamas\u0131 kullanmak, fiyat uyar\u0131lar\u0131 kurmak ve uzun vadeli d\u00fc\u015f\u00fcnmek \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r - LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r - LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T10:49:57+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-29T10:49:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/\",\"name\":\"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r - LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-29T10:49:57+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r - LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r - LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T10:49:57+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-29T10:49:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/","name":"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r - LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-29T10:49:57+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-lenz-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"LENZ Therapeutics, Inc. (LENZ) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; LENZ Therapeutics, Inc. (LENZ) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":357709,"slug":"how-to-buy-lenz-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu LENZ Therapeutics, Inc. (LENZ) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu LENZ Therapeutics, Inc. (LENZ)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-lenz-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":357702,"slug":"how-to-buy-lenz-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da LENZ Therapeutics, Inc. (LENZ) - Investimento em a\u00e7\u00f5es da LENZ Therapeutics, Inc. (LENZ)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-lenz-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/357706","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=357706"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/357706\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=357706"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=357706"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=357706"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}